Systemic therapy for previously untreated advanced BRAF-mutated melanoma: navigating a shifting landscape.

Subjects

Subjects :

Animals
Clinical Trials as Topic
Costimulatory and Inhibitory T-Cell Receptors immunology
Humans
MAP Kinase Kinase Kinases antagonists & inhibitors
Melanoma genetics
Melanoma immunology
Molecular Targeted Therapy
Pyridones therapeutic use
Pyrimidinones therapeutic use
Skin Neoplasms genetics
Skin Neoplasms immunology
Antibodies, Monoclonal therapeutic use
Antineoplastic Agents therapeutic use
Immunotherapy methods
Melanoma therapy
Mutation genetics
Proto-Oncogene Proteins B-raf genetics
Skin Neoplasms therapy

Details

Language :

English

ISSN :

1750-7448

Volume :

9

Issue :

5

Database :

MEDLINE

Journal :

Immunotherapy

Publication Type :

Editorial & Opinion

Accession number :

28357918

Full Text :

https://doi.org/10.2217/imt-2017-0023